224 related articles for article (PubMed ID: 32000644)
1. Inhibition of Hemoglobin Degrading Protease Falcipain-2 as a Mechanism for Anti-Malarial Activity of Triazole-Amino Acid Hybrids.
Singh V; Hada RS; Uddin A; Aneja B; Abid M; Pandey KC; Singh S
Curr Top Med Chem; 2020; 20(5):377-389. PubMed ID: 32000644
[TBL] [Abstract][Full Text] [Related]
2. Identification and structure-activity relationship (SAR) studies of carvacrol derivatives as potential anti-malarial against Plasmodium falciparum falcipain-2 protease.
Uddin A; Singh V; Irfan I; Mohammad T; Singh Hada R; Imtaiyaz Hassan M; Abid M; Singh S
Bioorg Chem; 2020 Oct; 103():104142. PubMed ID: 32763521
[TBL] [Abstract][Full Text] [Related]
3. A prodomain peptide of Plasmodium falciparum cysteine protease (falcipain-2) inhibits malaria parasite development.
Korde R; Bhardwaj A; Singh R; Srivastava A; Chauhan VS; Bhatnagar RK; Malhotra P
J Med Chem; 2008 Jun; 51(11):3116-23. PubMed ID: 18461922
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antimalarial effects of phenothiazine inhibitors of a Plasmodium falciparum cysteine protease.
Domínguez JN; López S; Charris J; Iarruso L; Lobo G; Semenov A; Olson JE; Rosenthal PJ
J Med Chem; 1997 Aug; 40(17):2726-32. PubMed ID: 9276017
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel class of falcipain-2 inhibitors as potential antimalarial agents.
Chakka SK; Kalamuddin M; Sundararaman S; Wei L; Mundra S; Mahesh R; Malhotra P; Mohmmed A; Kotra LP
Bioorg Med Chem; 2015 May; 23(9):2221-40. PubMed ID: 25840796
[TBL] [Abstract][Full Text] [Related]
6. Pyrido[1,2-a]pyrimidin-4-ones as antiplasmodial falcipain-2 inhibitors.
Mane UR; Li H; Huang J; Gupta RC; Nadkarni SS; Giridhar R; Naik PP; Yadav MR
Bioorg Med Chem; 2012 Nov; 20(21):6296-304. PubMed ID: 23040894
[TBL] [Abstract][Full Text] [Related]
7. Identification of antimalarial leads with dual falcipain-2 and falcipain-3 inhibitory activity.
Rana D; Kalamuddin M; Sundriyal S; Jaiswal V; Sharma G; Das Sarma K; Sijwali PS; Mohmmed A; Malhotra P; Mahindroo N
Bioorg Med Chem; 2020 Jan; 28(1):115155. PubMed ID: 31744777
[TBL] [Abstract][Full Text] [Related]
8. Identification of (4-(9H-fluoren-9-yl) piperazin-1-yl) methanone derivatives as falcipain 2 inhibitors active against Plasmodium falciparum cultures.
Hernández-González JE; Salas-Sarduy E; Hernández Ramírez LF; Pascual MJ; Álvarez DE; Pabón A; Leite VBP; Pascutti PG; Valiente PA
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2911-2923. PubMed ID: 30253205
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the antiplasmodial and falcipain-2 inhibitory activity of beta-amino alcohol thiolactone-chalcone and isatin-chalcone hybrids.
Hans RH; Gut J; Rosenthal PJ; Chibale K
Bioorg Med Chem Lett; 2010 Apr; 20(7):2234-7. PubMed ID: 20206517
[TBL] [Abstract][Full Text] [Related]
10. Hemoglobin cleavage site-specificity of the Plasmodium falciparum cysteine proteases falcipain-2 and falcipain-3.
Subramanian S; Hardt M; Choe Y; Niles RK; Johansen EB; Legac J; Gut J; Kerr ID; Craik CS; Rosenthal PJ
PLoS One; 2009; 4(4):e5156. PubMed ID: 19357776
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antimalarial activity of novel dihydro-artemisinin derivatives.
Liu Y; Cui K; Lu W; Luo W; Wang J; Huang J; Guo C
Molecules; 2011 May; 16(6):4527-38. PubMed ID: 21629181
[TBL] [Abstract][Full Text] [Related]
12. Pyrazole Schiff Base Hybrids as Anti-Malarial Agents: Synthesis, In Vitro Screening and Computational Study.
Aggarwal S; Paliwal D; Kaushik D; Gupta GK; Kumar A
Comb Chem High Throughput Screen; 2018; 21(3):194-203. PubMed ID: 29436997
[TBL] [Abstract][Full Text] [Related]
13. Quinoline carboxamide core moiety-based compounds inhibit P. falciparumfalcipain-2: Design, synthesis and antimalarial efficacy studies.
Singh A; Kalamuddin M; Maqbool M; Mohmmed A; Malhotra P; Hoda N
Bioorg Chem; 2021 Mar; 108():104514. PubMed ID: 33280833
[TBL] [Abstract][Full Text] [Related]
14. Falcipain-2 inhibition by suramin and suramin analogues.
Marques AF; Esser D; Rosenthal PJ; Kassack MU; Lima LM
Bioorg Med Chem; 2013 Jul; 21(13):3667-73. PubMed ID: 23680445
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity-relationship studies of thiazolidinediones as antiplasmodial inhibitors of the Plasmodium falciparum cysteine protease falcipain-2.
Sharma RK; Younis Y; Mugumbate G; Njoroge M; Gut J; Rosenthal PJ; Chibale K
Eur J Med Chem; 2015 Jan; 90():507-18. PubMed ID: 25486422
[TBL] [Abstract][Full Text] [Related]
16. Combating multi-drug resistant malaria parasite by inhibiting falcipain-2 and heme-polymerization: Artemisinin-peptidyl vinyl phosphonate hybrid molecules as new antimalarials.
Aratikatla EK; Kalamuddin M; Rana KC; Datta G; Asad M; Sundararaman S; Malhotra P; Mohmmed A; Bhattacharya AK
Eur J Med Chem; 2021 Aug; 220():113454. PubMed ID: 33901900
[TBL] [Abstract][Full Text] [Related]
17. The impact of whole genome sequence data on drug discovery--a malaria case study.
Joachimiak MP; Chang C; Rosenthal PJ; Cohen FE
Mol Med; 2001 Oct; 7(10):698-710. PubMed ID: 11713369
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and molecular docking study of novel triazole-quinazolinone hybrids as antimalarial and antitubercular agents.
Mhetre UV; Haval NB; Bondle GM; Rathod SS; Choudhari PB; Kumari J; Sriram D; Haval KP
Bioorg Med Chem Lett; 2024 Aug; 108():129800. PubMed ID: 38763480
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of gallinamide A analogues as potent falcipain inhibitors and antimalarials.
Conroy T; Guo JT; Elias N; Cergol KM; Gut J; Legac J; Khatoon L; Liu Y; McGowan S; Rosenthal PJ; Hunt NH; Payne RJ
J Med Chem; 2014 Dec; 57(24):10557-63. PubMed ID: 25412465
[TBL] [Abstract][Full Text] [Related]
20. Antimalarial activities of novel synthetic cysteine protease inhibitors.
Lee BJ; Singh A; Chiang P; Kemp SJ; Goldman EA; Weinhouse MI; Vlasuk GP; Rosenthal PJ
Antimicrob Agents Chemother; 2003 Dec; 47(12):3810-4. PubMed ID: 14638488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
